Evaluation of effects of levamisole and surgery on canine mammary cancer Journal Article


Authors: MacEwen, E. G.; Harvey, H. J.; Patnaik, A. K.; Mooney, S.; Hayes, A.; Kurzman, I.; Hardy, W. D. Jr
Article Title: Evaluation of effects of levamisole and surgery on canine mammary cancer
Abstract: Three hundred and forty-five dogs with mammary tumors were initially evaluated for study. One hundred and forty-four dogs with untreated malignant mammary tumors (136 adenocarcinomas, 5 malignant mixed, 3 sarcomas) were selected for study. All dogs were clinically staged and stratified on the basis of tumor volume and body weight. Dogs were randomized to either a radical mastectomy or simple mastectomy group, and then further randomized to a levamisole or placebo group. There was no significant difference in either survival time or cancer-free survival time between the surgery groups or between the levamisole and placebo groups. The most significant prognostic factor was tumor volume; dogs with tumors <41 cc had significantly enhanced survival time (p = 0.0007) and cancer-free survival time (p = 0.0005). © 1985 Raven Press, New York.
Keywords: survival; controlled study; placebo; drug efficacy; nonhuman; combined modality therapy; neoplasms; animals; cancer immunotherapy; breast cancer; breast; mastectomy; animal model; survival time; immunotherapy; dog; dog diseases; dogs; surgery; mammary glands, animal; therapy; intravenous drug administration; mammary tumors; levamisole; cancerfree interval
Journal Title: Journal of Biological Response Modifiers
Volume: 4
Issue: 4
ISSN: 0732-6580
Publisher: Lippincott-Raven  
Date Published: 1985-08-01
Start Page: 418
End Page: 426
Language: English
PUBMED: 4031952
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 26 October 2021 -- Source: Scopus
Citation Impact
MSK Authors
  1. William D Hardy
    25 Hardy